System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Published Erratum Epublish

PubMed: 42529191 DOI: 10.1016/j.lanepe.2026.101789

Corrigendum to "Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis" The Lancet Regional Health - Europe, Volume 60, January 2026, 101524.

Lancet Reg Health Eur 67:101789

Authors: Célia Dupain, Nicolas Jacquin, Aurélien Latouche, Zoé Nevière, Pierre Gestraud, Abderaouf Hamza, Kenza Nedara, Vincent Cockenpot, Janick Selves, Yves Allory, Laetitia Chanas, Maud Milder, Isabelle Soubeyran, Hélène Blons, Anna Patrikidou, Axel de Bernardi, Julien Masliah-Planchon, Odette Mariani, Etienne Rouleau, Fabienne Escande, Sandrine Boyault, Pierre Saintigny, Florence de Fraipont, Pierre Blanc, Jennifer Wong, Camille Tlemsani, Isabelle Guillou, Julie Flavius, Noemie Fuentealba, Maud Kamal, Ivan Bièche, Nicolas Servant, Christophe Le Tourneau, Sarah Watson

Affiliations

  • Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.
  • Department of Medical Oncology, Institut Curie, Paris, France.
  • Department of Medical Oncology, Institut Godinot, Reims, France.
  • INSERM U1331, Institut Curie, Saint-Cloud, France and Paris-Saclay University, Paris, France.
  • Conservatoire National des Arts et Metiers, Paris, France.
  • Department of Medical Oncology, Centre François Baclesse, Caen, France.
  • INSERM U1331, Curie CoreTech Bioinformatics (CUBIC), Institut Curie Research Center, Mines ParisTech, Paris, France.
  • Department of Genetics, Institut Curie, Paris, France.
  • INSERM U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Institut Cochin, Paris, France.
  • Department of Pathology, Institut Curie, Paris, France.
  • Department of Pathology, Institut Universitaire du Cancer Oncopole University Hospital of Toulouse, 31059, Toulouse, France.
  • Université Toulouse III-Paul Sabatier, F-31000, Toulouse, France.
  • Data Office, Institut Curie, Paris, France.
  • Department of Pathology, Institut Bergonié, Bordeaux, France.
  • Institut du Cancer Paris Carpem, APHP Centre, Department of Biology, Pharmacogenomics and Molecular Oncology Unit, Hôpital Européen Georges Pompidou, Paris, France.
  • Department of Cancer Medicine, Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France.
  • Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Center of Biological Ressources, Institut Curie, Paris, France.
  • Biology and Pathology Department, Cancer Genetic Service, Gustave Roussy Cancer Center, U981, Université Paris-Saclay, Villejuif, France.
  • CHRU Lille, Lille, France.
  • Department of Translationnal Research and Innovation, Centre de Recherche en Cancérologie de Lyon CRCL, INSERM U1052, CNRS UMR 5286, Centre Léon Bérard, UCBL1, Lyon, France.
  • CHU Grenoble, France.
  • Laboratoire SeqOIA, France.
  • Department of Medical Oncology, Hôpital Cochin, APHP Centre, Université Paris Cité, Paris, France.
  • INSERM U1339 CNRS UMR3666, PSL Research University, Institut Curie Research Center, Paris, France.

Abstract

[This corrects the article DOI: 10.1016/j.lanepe.2025.101524.].

MeSH

Neoplasms